Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice
Ryu‐Ichiro Hata(Kanagawa Dental University), Masaru Taniguchi(Nagoya City University)
Cited by 44
Related Papers
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
|PubMed|1998|382
Selective Ability of Mouse CD1 to Present Glycolipids: α-Galactosylceramide Specifically Stimulates Vα14+ NK T Lymphocytes
|The Journal of Immunology|1998|330
Coexistence of variable region of immunoglobulin heavy chain and I region gene products on antigen-specific suppressor T cells and suppressor T cell factor
|Molecular Immunology|1980|48
Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma
|Cancer Science|2009|44
MULTIPLE MHC LOCI CONTROLLING LYMPHOCYTE INTERACTIONS
|Elsevier eBooks|1979|13